L Andera Selected Research

Cytokines

3/2013	Upregulation of c-FLIP-short in response to TRAIL promotes survival of NSCLC cells, which could be suppressed by inhibition of Ca2+/calmodulin signaling.
1/2013	Multi-level disruption of the extrinsic apoptotic pathway mediates resistance of leukemia cells to TNF-related apoptosis-inducing ligand (TRAIL).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

L Andera Research Topics

Disease

7	Neoplasms (Cancer) 03/2013 - 01/2002
1	Adenocarcinoma of Lung 03/2013
1	Adenocarcinoma 03/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2013
1	Leukemia 01/2013
1	Colorectal Neoplasms (Colorectal Cancer) 07/2007
1	Necrosis 07/2007
1	Malignant Mesothelioma 04/2004

Drug/Important Bio-Agent (IBA)

2	TNF-Related Apoptosis-Inducing LigandIBA 03/2013 - 01/2013
2	CytokinesIBA 03/2013 - 01/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 01/2002
2	LigandsIBA 07/2007 - 01/2002
1	Caspase 8 (Caspase-8)IBA 03/2013
1	Fas Ligand Protein (Fas Ligand)IBA 07/2007
1	Succinic Acid (Succinate)IBA 04/2004
1	Vitamin E FDA LinkGeneric 04/2002

Therapy/Procedure

3	Therapeutics 01/2010 - 01/2006